These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8605946

  • 1. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
    Seeman P, Guan HC, Van Tol HH.
    Eur J Pharmacol; 1995 Nov 14; 286(2):R3-5. PubMed ID: 8605946
    [Abstract] [Full Text] [Related]

  • 2. The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
    Marzella PL, Hill C, Keks N, Singh B, Copolov D.
    Biol Psychiatry; 1997 Oct 15; 42(8):648-54. PubMed ID: 9325557
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
    Seeman P, Van Tol HH.
    J Neurochem; 1995 Mar 15; 64(3):1413-5. PubMed ID: 7861175
    [Abstract] [Full Text] [Related]

  • 4. Are striatal dopamine D4 receptors increased in schizophrenia?
    Reynolds GP, Mason SL.
    J Neurochem; 1994 Oct 15; 63(4):1576-7. PubMed ID: 7931313
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P, Guan HC, Van Tol HH.
    Nature; 1993 Sep 30; 365(6445):441-5. PubMed ID: 8413587
    [Abstract] [Full Text] [Related]

  • 6. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG.
    Brain Res; 1997 Aug 08; 765(1):7-12. PubMed ID: 9310388
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Noda-Saita K, Matsumoto M, Hidaka K, Hatanaka K, Ohmori J, Okada M, Yamaguchi T.
    Biochem Biophys Res Commun; 1999 Feb 16; 255(2):367-70. PubMed ID: 10049714
    [Abstract] [Full Text] [Related]

  • 8. Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia.
    Reynolds GP, Mason SL.
    Eur J Pharmacol; 1995 Aug 04; 281(2):R5-6. PubMed ID: 7589196
    [Abstract] [Full Text] [Related]

  • 9. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
    Helmeste DM, Tang SW, Bunney WE, Potkin SG, Jones EG.
    Eur J Pharmacol; 1996 Oct 31; 314(3):R3-5. PubMed ID: 8957266
    [Abstract] [Full Text] [Related]

  • 10. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
    Murray AM, Hyde TM, Knable MB, Herman MM, Bigelow LB, Carter JM, Weinberger DR, Kleinman JE.
    J Neurosci; 1995 Mar 31; 15(3 Pt 2):2186-91. PubMed ID: 7891160
    [Abstract] [Full Text] [Related]

  • 11. Regional distribution of dopamine D4 receptors in rat forebrain.
    Tarazi FI, Kula NS, Baldessarini RJ.
    Neuroreport; 1997 Nov 10; 8(16):3423-6. PubMed ID: 9427299
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
    Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY.
    Brain Res; 1995 May 29; 681(1-2):109-16. PubMed ID: 7552267
    [Abstract] [Full Text] [Related]

  • 13. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.
    Murray AM, Ryoo HL, Gurevich E, Joyce JN.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):11271-5. PubMed ID: 7972046
    [Abstract] [Full Text] [Related]

  • 14. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug 08; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 15. Multiple [3H]-nemonapride binding sites in calf brain.
    Helmeste DM, Tang SW, Li M, Fang H.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 08; 356(1):17-21. PubMed ID: 9228185
    [Abstract] [Full Text] [Related]

  • 16. Quantitative analysis of the dopamine D4 receptor in the mouse brain.
    Defagot MC, Falzone TL, Low MJ, Grandy DK, Rubinstein M, Antonelli MC.
    J Neurosci Res; 2000 Jan 15; 59(2):202-8. PubMed ID: 10650878
    [Abstract] [Full Text] [Related]

  • 17. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 15; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 18. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN.
    Arch Gen Psychiatry; 1997 Mar 15; 54(3):225-32. PubMed ID: 9075463
    [Abstract] [Full Text] [Related]

  • 19. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM, D'Souza UM, Strange PG.
    J Neurochem; 1995 Feb 15; 64(2):940-3. PubMed ID: 7830089
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic localization of the putative D4 dopamine receptor in rat brain.
    Defagot MC, Antonelli MC.
    Neurochem Res; 1997 Apr 15; 22(4):401-7. PubMed ID: 9130250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.